- Home
- Life Sciences
- Biotechnology
- Biotechnology Analysis & Statistics, November 2011 (p40)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
Publication dates
Publishers
- Global Data (609)
- Bioseeker (59)
- MarketLine (254)
- Euromonitor International (50)
- BCC Research (54)
-
- Global Markets Direct (280)
- La Merie Publishing (64)
- Currentpartnering (117)
- Ibisworld (12)
- Asia Market Information & Development Company (8)
- CCM International Limited (33)
- France Innovation Scientifique et Transfert (5)
- Infiniti Research Limited (23)
- Kuick Research (3)
- MarketsandMarkets (19)
- RNCOS (18)
- Transparency Market Research (7)
- IData Research, Inc. (59)
- CHI Insight Pharma Reports (19)
- Canadean Ltd (18)
- Datamonitor (101)
- Frost & Sullivan (64)
- Global Research & Data Services (1)
- Mind Commerce Publishing (1)
- World Market Intelligence Ltd (5)
- Life Science Analytics (LSA) (255)
- Global Industry Analyst (45)
- ICD Research (37)
- GBI Research (36)
- Espicom Business Intelligence (30)
- SCRIP Insights (28)
- Axis Research Mind (22)
- Freedonia (22)
- Koncept Analytics (22)
- Visiongain (22)
- BioPharm Reports (18)
- Kalorama Information (18)
- Aruvian's R'search (16)
- Business Review (14)
- ABMRG (11)
- BioInformatics (11)
- TriMark Publications (10)
- BioPlan Associates, Inc. (9)
- Daedal Research (9)
- Research In China (9)
- Industry Experts (8)
- Venture Planning Group (8)
- IPEXL (6)
- Beijing Zeefer Consulting Ltd (5)
- WinterGreen Research (5)
- International Market Analysis Research and Consult (4)
- Pharmavision (4)
- Dolcera Corporation (3)
- Plimsoll Publishing Ltd UK (3)
- Firstword Pharma (2)
- OECD (2)
- Packaged Facts (2)
- Plunkett Research (2)
- Smart Research Insights (2)
- The Centre for Food & Health Studies (2)
- International Research Report (1)
- Arena (1)
- Arrowhead (1)
- Asianet-Pakistan (1)
- Barnes Reports (1)
- Global Industry Analysts (1)
- Grey House Publishing (1)
- Greystone Research Associates (1)
- Ken Research Private (1)
- Netscribes (India) Pvt. Ltd. (1)
- PMR Ltd. (1)
- Renub Research (1)
- Reports from China (1)
- SeeNews - Research & Profiles (1)
- Urch Publishing (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
-
- Armenia (1)
- Azerbaijan (1)
- Bahrain (1)
- China (116)
- Georgia (4)
- India (59)
- Indonesia (2)
- Iran (2)
- Israel (14)
- Japan (70)
- Jordan (1)
- Kazakhstan (1)
- Kuwait (1)
- Lebanon (1)
- Malaysia (11)
- Pakistan (1)
- Philippines (1)
- Qatar (1)
- Saudi Arabia (2)
- Singapore (9)
- South Korea (34)
- Syrian Arab Republic (1)
- Taiwan (13)
- Thailand (2)
- United Arab Emirates (1)
- Uzbekistan (1)
- Vietnam (2)
- Yemen (1)
-
- Austria (5)
- Belgium (14)
- Bulgaria (1)
- Croatia (1)
- Czech Republic (5)
- Denmark (16)
- Finland (7)
- France (29)
- Germany (43)
- Greece (3)
- Hungary (3)
- Ireland (6)
- Italy (25)
- Latvia (1)
- Lithuania (1)
- Luxembourg (1)
- Macedonia (1)
- Netherlands (19)
- Norway (4)
- Poland (4)
- Portugal (6)
- Romania (2)
- Russian Federation (6)
- Serbia and Montenegro (1)
- Slovakia (slovak Republic) (1)
- Slovenia (1)
- Spain (27)
- Sweden (13)
- Switzerland (27)
- Ukraine (2)
- United Kingdom (36)
-
- Australia (50)
- Austria (5)
- Belgium (14)
- Canada (64)
- Chile (2)
- Czech Republic (5)
- Denmark (16)
- Finland (7)
- France (29)
- Germany (43)
- Greece (3)
- Hungary (3)
- Ireland (6)
- Israel (14)
- Italy (25)
- Japan (70)
- Luxembourg (1)
- Mexico (6)
- Netherlands (19)
- New Zealand (7)
- Norway (4)
- Poland (4)
- Portugal (6)
- Slovenia (1)
- South Korea (34)
- Spain (27)
- Sweden (13)
- Switzerland (27)
- United Kingdom (36)
- United States (738)
Free Market Research Guides to Download
Biotechnology Analysis & Statistics, November 2011 (p40)
You might be interested in: biotech, biomedical, biomaterials, more »
» Purchase Premium Reports
1171-1200 of about 2 200 reports
BIOBANKING: TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015
- $ 3 360
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Genomics
- Countries : World
BIOBANKING: APPLICATIONS - A GLOBAL MARKET WATCH, 2009-2015
- $ 3 180
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Genomics
- Countries : World
BIOREPOSITORIES: OWNERSHIP & END-USERS - A GLOBAL MARKET WATCH, 2009-2015
- $ 3 270
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: EQUIPMENTS & OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 710
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: TECHNOLOGIES & OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 440
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
Product Profiles: Targeted Cancer Therapies - - Trend towards personalized medicine will lead to industry fragmentation
- $ 11 400
- Industry report
- November 2011
- by Datamonitor
About This Report The targeted therapies class boasts several of the top-selling anticancer brands, and has fueled most of the recent rapid growth of the oncology industry as a whole. In the next decade, ...
- Industries : Biological Therapy
- Countries : United States
Next-Generation Antibody Therapies: Pipeline and Market 2011-2021
- $ 2 730
- Industry report
- November 2011
- by Visiongain
Report Details What are the prospects for emerging antibody technologies? Visiongain's report shows you potential revenues to 2021, discussing R&D trends and opportunities. A new generation of therapeutic ...
- Industries : Biopharmaceutical
- Countries : United States
BIOREPOSITORIES: APPLICATIONS & OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 170
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: TECHNOLOGIES & END-USERS - A GLOBAL MARKET WATCH, 2009-2015
- $ 3 720
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: APPLICATIONS & END-USERS - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 260
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: APPLICATIONS & TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 530
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: EQUIPMENTS & TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 350
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: EQUIPMENTS & APPLICATIONS - A GLOBAL MARKET WATCH, 2009-2015
- $ 4 620
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
BIOREPOSITORIES: EQUIPMENTS, APPLICATIONS, TECHNOLOGIES, OWNERSHIP AND END-USERS - AN ANALYTICAL REPORT, 2009-2015
- $ 6 600
- Industry report
- November 2011
- by Axis Research Mind
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
- Industries : Biological Therapy
- Countries : World
Strategic Analysis of the U.S. Next-Generation Sequencing Services Market
- $ 6 000
- Industry report
- November 2011
- by Frost & Sullivan
This research search analyzes the next-generation sequencing services market within the United Sates. The Next-Generation Sequencing Services Market includes all sequencing services conducted with next-generation ...
- Industries : Genomics
- Countries : United States
Synthetic Biology: Emerging Global Markets
- $ 5 450
- Industry report
- November 2011
- by BCC Research
REPORT SCOPE INTRODUCTION STUDY GOAL AND OBJECTIVES BCC's goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a 5-year period ...
- Industries : Genetically Modified Organism, Gmo
- Countries : World
Seikagaku Corporation Market Share Analysis
- $ 1 000
- Company report
- October 2011
- by Global Data
Seikagaku Corporation Market Share Analysis Summary GlobalData's new report, ?Seikagaku Corporation Market Share Analysis? provides in-depth information on Seikagaku Corporation's market position in the ...
- Industries : Biomaterial
- Countries : World
Biomet Profile (Biomaterials): Global Market Share Analysis by region, SWOT, Product Pipeline & Financials 2012
- $ 1 995
- Company report
- October 2011
- by iData Research, Inc.
Biomet is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a number of emerging markets. Throughout its history, the company has also ...
- Industries : Biomaterial
- Countries : World
Dyax Corporation SWOT
- $ 175
- Company report
- October 2011
- by MarketLine
examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Dyax, a development stage biopharmaceutical firm ...
- Industries : Biopharmaceutical
- Countries : United States
Celgene Corporation SWOT
- $ 175
- Company report
- October 2011
- by MarketLine
Celgene Corporation - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. The market research report examines the firm ?s key business structure ...
- Industries : Biopharmaceutical
- Countries : United States
Genomics in United States: Human Genome Sciences, Inc. - SWOT analysis
- $ 175
- Company report
- October 2011
- by MarketLine
Human Genome Sciences, Inc. - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. Human Genome Sciences, Inc. - SWOT Analysis examines the ...
- Industries : Genomics
- Countries : United States
World Biological Therapy: Fracture - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Biological Therapy
- Countries : World
World Biological Therapy: Myelofibrosis - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Biological Therapy
- Countries : World
World Biopharmaceutical: Growth Hormone Deficiency - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Biopharmaceutical
- Countries : World
World Biological Therapy: Neutropenia - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Neutropenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Biological Therapy
- Countries : World
World Biological Therapy: Amyloidosis - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Biological Therapy
- Countries : World
World Biological Therapy: Cirrhosis - Pipeline Review, H2 2011
- $ 500
- Industry report
- October 2011
- by Global Markets Direct
This report provides information on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Biological Therapy
- Countries : World
Genomics: CapitalBio Corporation
- $ 750
- Industry report
- October 2011
- by Global Data
This report is a source for data, analysis and actionable intelligence on the CapitalBio Corporation portfolio of new product development . The report provides detailed analysis on each pipeline product ...
- Industries : Genomics
Drug Discovery and Development: Nanovis Incorporated
- $ 750
- Industry report
- October 2011
- by Global Data
This report is a source for data, analysis and actionable intelligence on the Nanovis Incorporated portfolio of new product development . The report provides detailed analysis on each pipeline product ...
- Industries : Biomaterial
Biomaterial: ThermoGenesis Corp. (KOOL)
- $ 750
- Industry report
- October 2011
- by Global Data
This report is a source for data, analysis and actionable intelligence on the ThermoGenesis Corp. portfolio of new product development . The report provides detailed analysis on each pipeline product ...
- Industries : Biomaterial
» Download Public Reports
About 9 000 reports
Intercell AG - Company Report for Year 2013
- Company report
- May 2013
- 4 pages
... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...
Biotechnology Sector In Japan
April 2013U.s. Gmo Sector Brief
May 2013» Read our Company Profiles
99 CompaniesNutrition Co.
United StatesGlaxoSmithKline P.L.C.
United StatesJohnson and Johnson
United StatesSanofi-Aventis Senegal
SenegalBiogen Idec
United StatesReportlinker.com © Copyright 2013. All rights reserved.
